Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Vandenberk · SciRah

Researcher profile · Semantic Scholar

L. Vandenberk

Share profile

L. Vandenberk — researcher profile on SciRah

h-index: 14
Works: 29
Citations: 1,365

Most-cited papers

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D Garg, L. Galluzzi, L. Apetoh, T. Baert +48 more
2015Frontiers in Immunology383 citations Open access
Semantic Scholar
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
Abhishek D Garg, L. Vandenberk, C. Koks, Tina Verschuere +3 more
2016Science Translational Medicine246 citations
Semantic Scholar
Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death
C. Koks, A. Garg, M. Ehrhardt, M. Riva +6 more
2015International Journal of Cancer214 citations Open access
Semantic Scholar
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing
A. Garg, L. Vandenberk, Shentong Fang, Tekele Fasche +10 more
2017Cell Death and Differentiation107 citations Open access
Semantic Scholar
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
L. Vandenberk, J. Belmans, Matthias van Woensel, M. Riva +1 more
2016Frontiers in Immunology89 citations Open access
Semantic Scholar
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
Abhishek D Garg, L. Vandenberk, Matthias van Woensel, J. Belmans +4 more
2017Oncoimmunology66 citations Open access
Semantic Scholar
Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.
Bhagirathbhai R. Dholaria, K. Weisel, M. Mateos, H. Goldschmidt +16 more
2023Journal of Clinical Oncology59 citations Open access
Semantic Scholar
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
L. Vandenberk, Abhishek D Garg, Tina Verschuere, C. Koks +5 more
2015Oncoimmunology53 citations Open access
Semantic Scholar
A novel, immunotherapy-based approach for the treatment of relapsed/refractory multiple myeloma (RRMM): Updated phase 1b results for daratumumab in combination with teclistamab (a BCMA x CD3 bispecific antibody).
P. Rodríguez-Otero, A. D'Souza, D. Reece, N. V. van de Donk +16 more
2022Journal of Clinical Oncology28 citations
Semantic Scholar
Teclistamab, Daratumumab, and Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Majestec-2 Cohort a and Trimm-2 Studies
Anita D'Souza, Luciano J. Costa, J. San-Miguel, J. Berdeja +22 more
2024Blood27 citations
Semantic Scholar
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.
A. Chari, N. V. van de Donk, Bhagirathbhai R. Dholaria, K. Weisel +22 more
2025Blood24 citations Open access
Semantic Scholar
Treg infiltration in glioma: a hurdle for antiglioma immunotherapy.
L. Vandenberk, S. van Gool
2012Immunotherapy24 citations
Semantic Scholar
S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB
N. W. van de Donk, N. Bahlis, M. Mateos, K. Weisel +22 more
2022HemaSphere14 citations Open access
Semantic Scholar
S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS
P. R. Otero, A. D'Souza, D. Reece, N. W. van de Donk +16 more
2022HemaSphere14 citations Open access
Semantic Scholar
S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
N. Bahlis, K. Weisel, M. Mateos, H. Goldschmidt +16 more
2023HemaSphere7 citations Open access
Semantic Scholar
OA-01 Talquetamab (tal) + Daratumumab (dara) + Pomalidomide (pom) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 1b TRIMM-2 Study
Nizar J. Bahlis, N. V. van de Donk, Donna Reece, M. Bhutani +12 more
2024Clinical Lymphoma, Myeloma & Leukemia6 citations
Semantic Scholar
Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide
D. Vishwamitra, Sheri Skerget, Diana Cortes, Kalpana K. Bakshi +29 more
2024Blood4 citations
Semantic Scholar
MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results
B. Dholaria, K. Weisel, M. Mateos, H. Goldschmidt +16 more
2023Clinical Lymphoma, Myeloma & Leukemia2 citations Open access
Semantic Scholar
689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2
D. Vishwamitra, Sheri Skerget, M. Smit, L. Vandenberk +9 more
2023Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
Next-generation immunogenic dendritic cell vaccines achieve a danger signaling and T cell-driven eradication of high-grade glioma
Abhishek D Garg, L. Vandenberk, C. Koks, Tina Verschuere +2 more
20161 citations
Semantic Scholar
Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma
L. Vandenberk, Abhishek D Garg, P. Agostinis, Tina Verschuere +3 more
2014Journal of Immunotherapy for Cancer1 citations Open access
Semantic Scholar
Complementary immunomodulatory effects of talquetamab plus daratumumab with or without pomalidomide in multiple myeloma
D. Vishwamitra, Sheri Skerget, Kalpana K. Bakshi, L. Vandenberk +12 more
2026Blood Immunology & Cellular Therapy0 citations Open access
Semantic Scholar
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.
P. Rodríguez-Otero, Daniel Morillo, Anita D'Souza, Donna Reece +26 more
2026Blood Advances0 citations Open access
Semantic Scholar
SP-0114 Immunogenic versus Non-Immunogenic Cell Death in Cancer
Abhishek D Garg, L. Vandenberk, Shentong Fang, P. de Witte +2 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
Online Media Press Releases - Garg et al. 2016 STM
Abhishek D Garg, L. Vandenberk, C. Koks, Tina Verschuere +3 more
20160 citations
Semantic Scholar
Immunogenic oxidative therapy-based next-generation dendritic cell vaccines against high-grade glioma
L. Vandenberk
20160 citations
Semantic Scholar
Irradiation of freeze-thaw lysate used to pulse dendritic cells further increases antitumor immunity in a mouse model of high-grade glioma
L. Vandenberk, S. Gool, Tina Verschuere, C. Koks +3 more
20140 citations
Semantic Scholar
In-vitro and in-vivo effects of Cilengitide in Glioblastoma models
J. Schubert, C. Mullins, S. van Gool, L. Vandenberk +2 more
20130 citations
Semantic Scholar
Immunotherapy for malignant glioma: preclinical models to improve efficacy of the immune attack
L. Vandenberk, Tina Verschuere, K. Vanhoven, C. KDks +2 more
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Agostinis×11
Invite
P. Agostinis — researcher profile on SciRah
N. V. van de Donk×10
Invite
N. V. van de Donk — researcher profile on SciRah
Abhishek D Garg×9
Invite
Abhishek D Garg — researcher profile on SciRah
S. van Gool×9
Invite
S. van Gool — researcher profile on SciRah

×8

Invite

C. Koks — researcher profile on SciRah

Invite

A. Oriol — researcher profile on SciRah

D. Vishwamitra×8

Invite

D. Vishwamitra — researcher profile on SciRah

Tina Verschuere×7

Invite

Tina Verschuere — researcher profile on SciRah

P. Rodríguez-Otero×7

Invite

P. Rodríguez-Otero — researcher profile on SciRah

Invite

M. Bhutani — researcher profile on SciRah

Invite

A. Chari — researcher profile on SciRah

Kalpana K. Bakshi×7

Invite

Kalpana K. Bakshi — researcher profile on SciRah